Endovision Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Pune, Maharashtra, India, established in 2021.
2021 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Endovision Pharma Private Limited

Endovision Pharma Private Limited, a active private limited company, was established on 10 February 2021 in Pune, Maharashtra, India. Engaging in medical consumables & supplies within the healthcare sector, it holds CIN: U51909PN2021PTC198478. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Yogita Prashant Jagadale (Director), Prashant Bhanudas Jagadale (Director). Past directors included Manish Subhash Oswal, Swarada Jitendra Prabhune. Its latest AGM occurred on 31 December 2022, with the balance sheet filed on 31 March 2022. It is based at S.No.241/2/1 New D.P.Road, Pune, Maharashtra, 411007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909PN2021PTC198478

  • Registration Number

    198478

  • Incorporation Date

    10 February 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 4 Days
  • Last Filing with ROC 31 Mar 2022
Company report

Endovision Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Endovision Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Endovision Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Yogita Prashant Jagadale Director 28 Aug 2025 Current
Prashant Bhanudas Jagadale Director 10 Feb 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Aug 2025 Past
Pramod Abcsdd Director 28 Aug 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Endovision Pharma.

Enhance accessibility to Endovision Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Endovision Pharma revenue growth over time
Endovision Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Endovision Pharma?

Unlock access to Endovision Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Endovision Pharma?

Endovision Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Endovision Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endovision Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Endovision Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Yogita Prashant Jagadale was appointed as a Director was appointed as a Director on 28 Aug 2025 & has been associated with this company since 5 months 19 days . was completed.

  • Annual General Meeting

    Endovision Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Endovision Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was documented.

  • Director Appointment

    Progress on Prashant Bhanudas Jagadale was appointed as a Director was appointed as a Director on 10 Feb 2021 & has been associated with this company since 5 years 4 days . was documented.

  • Company Incorporation

    Endovision Pharma Private Limited was registered on 10 Feb 2021 with Roc Pune & aged 5 years 4 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Endovision Pharma Private Limited?

The CIN of Endovision Pharma Private Limited is U51909PN2021PTC198478.

Where is Endovision Pharma Private Limited headquartered?

Endovision Pharma Private Limited is headquartered at S.No.241/2/1 New D.P.Road, Pune, Maharashtra, 411007.

When was Endovision Pharma Private Limited incorporated?

Endovision Pharma Private Limited was incorporated on 10 February 2021.

Who are the current directors of Endovision Pharma Private Limited?

The current directors of Endovision Pharma Private Limited are

What is the primary industry of Endovision Pharma Private Limited?

The primary industry of Endovision Pharma Private Limited is Healthcare.

Is Endovision Pharma Private Limited a listed company?

Endovision Pharma Private Limited is unlisted.

What is the capital structure of Endovision Pharma Private Limited?

The authorized capital of Endovision Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available